The U.S. Court of Appeals for the Federal Circuit (CAFC) reversed a district court’s decision in Snaprays (dba SnapPower), v.
A client’s recent experience applying for a European patent led to the development of a possible optimization strategy to address patent costs for clients. This client had made an initial U.S. filing ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision today vacating and remanding with ...
“Using section 1498 would not significantly reduce drug costs because, as courts have repeatedly recognized, the law requires the government to provide ‘reasonable and entire compensation’ for any ...
The U.S. Patent and Trademark Office (USPTO) recently released new guidance for practitioners using artificial intelligence ...
“[T]he Federal Circuit noted that questions about a party’s ability to license patent rights do not provide a reasonable ...
Expansion to FTC’s Orange Book Campaign Leads to Calls for More Clarity from Pharmaceutical Industry
On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper ...
“The stated goal of facilitating commercialization in particular may seem contradictory to some, considering the ...
The U.S. Senate Judiciary Committee’s Subcommittee on Intellectual Property met today to hear from six witnesses about a ...
Standard Essential Patent (SEP) litigation is global and SEP owners often follow a strategy to enforce their SEPs in multiple ...
Law Community of the District of Columbia (DC) Bar will honor two exceptional individuals, Professor Victoria Phillips and ...
The U.S. Court of Appeals for the Federal Circuit (CAFC) today issued a precedential trademark decision affirming a Trademark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results